AC Immune S.A. (ACIU) — Financial statements
Income statement, balance sheet, and cash flow for AC Immune S.A. — annual and quarterly history with growth and margin analysis.
| Metric (CHF Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 4↓86.9% | 27↑84.5% | 15↑276.1% | 4 | 0.00 | |
| Cost of Revenue | 0.00↓100.0% | 63↑14.6% | 55 | 0.00 | 0.00 | |
| Gross Profit | 4↑110.1% | -35↑11.4% | -40↓1111.6% | 4 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 56↓9.8% | 63↑14.6% | 55↓9.5% | 60↓3.1% | 62 | |
| General & Administrative Expenses | 12↑1.9% | 11↑8.1% | 11↑10.4% | 10↓11.9% | 11 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 12↑1.9% | 11↑8.1% | 11↑10.4% | 10↓11.9% | 11 | |
| Other Expenses | 4↑107.6% | -57↓10.8% | -51↓1156.0% | 5↓16.8% | 6 | |
| Operating Expenses | 72↑323.2% | 17↑23.9% | 14↓81.5% | 75↓5.4% | 79 | |
| Total Costs & Expenses | 72↓9.1% | 80↑16.5% | 68↓8.5% | 75↓5.4% | 79 | |
| Operating Results | ||||||
| Operating Income | -69↓31.5% | -52↑2.3% | -54↑24.3% | -71↑10.3% | -79 | |
| Depreciation & Amortization | 3↑15.8% | 2↓2.4% | 2↓6.1% | 2↓2.0% | 2 | |
| EBITDA | -68↓39.4% | -49↑6.2% | -52↑23.8% | -68↑2.8% | -70 | |
| EBIT | -70↓38.4% | -51↑6.0% | -54↑23.2% | -70↑2.8% | -72 | |
| Interest & Other Income | ||||||
| Net Interest Income | 2↓45.3% | 3↑252.9% | 0.87↑403.5% | -0.29↓104.8% | 6 | |
| Interest Income | 2↓41.6% | 3↑206.1% | 1↑1413.0% | 0.07↓98.9% | 6 | |
| Interest Expense | 0.19↑43.6% | 0.13↓24.4% | 0.18↓50.4% | 0.36↓38.9% | 0.58 | |
| Non-Operating Income | 1↑187.2% | -2↓477.8% | 0.42↑191.6% | -0.46↑93.0% | -7 | |
| Other Income / Expenses | -2↓208.1% | 1↑344.6% | -0.60↓659.8% | 0.11↓98.2% | 6 | |
| Income Before Tax | -70↓38.4% | -51↑6.1% | -54↑23.3% | -71↑3.1% | -73 | |
| Income Tax Expense | 0.00↓100.0% | 0.00↓70.0% | 0.01↓23.1% | 0.01↑333.3% | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -70↓38.4% | -51↑6.1% | -54↑23.3% | -71↑3.1% | -73 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -70↓38.4% | -51↑6.1% | -54↑23.3% | -71↑3.1% | -73 | |
| Bottom-Line Net Income | -70↓38.4% | -51↑6.1% | -54↑23.3% | -71↑3.1% | -73 | |
| EPS (Basic) | -0.70↓37.3% | -0.51↑20.3% | -0.64↑24.7% | -0.85↑12.4% | -0.97 | |
| EPS (Diluted) | -0.70↓37.3% | -0.51↑20.3% | -0.64↑24.7% | -0.85↑12.4% | -0.97 | |
| Weighted Average Shares | 101↑1.1% | 100↑17.7% | 85↑1.4% | 84↑11.5% | 75 | |
| Weighted Average Diluted Shares | 101↑1.1% | 100↑17.7% | 85↑1.4% | 84↑11.5% | 75 | |
* All figures in Millions of CHF, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.